J&J

164 results

GlaxoSmithKline has led the way in relation to Big-Pharma transparency, breaking with its peers on stopping the practice of paying speaking fees to doctors for talking to audiences about its medicines. Photograph: Reuters/Toby Melville

It appears that Big Pharma is waking up to the need for greater transparency in how it conducts business. Since January 1st, pharmaceutical companies (...)

Jan Rosier, newly appointed Institute Élan Professor of The Business of Biotechnology at the UCD Conway Institute

An amusing and probably apocryphal story did the rounds of the British research community some years back. It concerned a conversation between a he(...)

Planet Business

Image of the week: Detroit devilThe posters depict Michigan governor Rick Snyder, with some Halloween-style alterations, during a protest against the (...)

 US stocks rose as plans for President Barack Obama and Vice President Joe Biden to meet congressional leaders raised hopes that a resolution to the fiscal impasse was closer, but the Columbus Day holiday meant volumes were lower than usual. Photographer: Scott Eells/Bloomberg

European markets held their own or ticked up slightly for the most part as they awaited further developments in the US shut-down saga, which it is now(...)

For your diary

TODAYResults: Boston Scientific; Zynga. Meetings: Senior enterprise forum (Knightsbridge Hotel, Co Meath).Indicators: Irish quarterly institutional se(...)

J&J has asked JPMorgan Chase to run the sale

Johnson & Johnson (J&J) has launched a sale process for its Ortho Clinical Diagnostics unit which makes blood screening equipment and laborato(...)

If you are strolling through Her- bert Park in Ballsbridge next Thursday, don’t be alarmed if you see Alan Murphy, the man- aging partner of Eversheds(...)

Ashifi Gogo: Sproxil system allows legitimacy of medication to be checked

Ashifi Gogo came straight from an awards ceremony at the White House to speak at the HealthXL Global Gathering in Dublin last month. A native of Ghana(...)

Elan chief executive Kelly Martin: the firm faces a critical moment in its volatile history with tomorrow’s EGM.

Irish biotech group Elan has been through many critical moments in its volatile history. Tomorrow, shareholders gather for an extraordinary general me(...)

One minute, Elan’s suitor, Royalty Pharma, was warning it might be forced to walk away as shareholders appeared certain to back a proposal by the Iris(...)

  • « First
  • Prev
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next
  • Last »